Hypersensitivity  >>  Veramyst (fluticasone furoate nasal spray)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Veramyst (fluticasone furoate nasal spray) / GSK
NCT00275561: Topical Steroid Treatment for Eosinophilic Esophagitis

Completed
2
42
US
Fluticasone, Flonase, Veramyst, Placebo
Mayo Clinic
Eosinophilic Esophagitis
04/10
04/10
NCT01957202 / 2013-002940-94: A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

Completed
2
71
Europe
FF/levocabastine, FF, levocabastine, Placebo
GlaxoSmithKline
Rhinitis, Allergic, Perennial and Seasonal
02/14
02/14
NCT01808339: To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

Completed
2
28
RoW
Fluticasone Furoate (FF), Placebo
GlaxoSmithKline
Asthma
03/14
03/14
NCT01563029: A Dose-ranging Study of Fluticasone Furoate (FF)

Completed
2
597
Japan, US, Europe, RoW
Fluticasone Furoate, Fluticasone Propionate, Placebo
GlaxoSmithKline
Asthma
09/14
09/14

Download Options